These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 16703733

  • 21. Therapeutic effectiveness and patient satisfaction after 6 months of treatment with tadalafil, sildenafil, and vardenafil: results from the erectile dysfunction observational study (EDOS).
    Martin-Morales A, Haro JM, Beardsworth A, Bertsch J, Kontodimas S, EDOS Group.
    Eur Urol; 2007 Feb; 51(2):541-50; discussion 550. PubMed ID: 17084518
    [Abstract] [Full Text] [Related]

  • 22. A randomized open-label trial with a crossover comparison of sexual self-confidence and other treatment outcomes following tadalafil once a day vs. tadalafil or sildenafil on-demand in men with erectile dysfunction.
    Rubio-Aurioles E, Porst H, Kim ED, Montorsi F, Hackett G, Morales AM, Stuckey B, Būttner H, West TM, Huynh NN, Lenero E, Burns P, Kopernicky V.
    J Sex Med; 2012 May; 9(5):1418-29. PubMed ID: 22429760
    [Abstract] [Full Text] [Related]

  • 23. Psychosocial outcomes after initial treatment of erectile dysfunction with tadalafil once daily, tadalafil on demand or sildenafil citrate on demand: results from a randomized, open-label study.
    Hatzimouratidis K, Buvat J, Büttner H, Vendeira PA, Moncada I, Boehmer M, Henneges C, Boess FG.
    Int J Impot Res; 2014 May; 26(6):223-9. PubMed ID: 24784894
    [Abstract] [Full Text] [Related]

  • 24. Patterns of treatment with PDE5 inhibitors in the clinical practice in Italy: longitudinal data from the Erectile Dysfunction Observational Study.
    Fusco F, Sicuteri R, Rossi A, Kontodimas S, Haro JM, Imbimbo C, Mirone V, Italian EDOS Study Group.
    Asian J Androl; 2009 Sep; 11(5):629-37. PubMed ID: 19701217
    [Abstract] [Full Text] [Related]

  • 25. Comparison of clinical trials with sildenafil, vardenafil and tadalafil in erectile dysfunction.
    Doggrell SA.
    Expert Opin Pharmacother; 2005 Jan; 6(1):75-84. PubMed ID: 15709885
    [Abstract] [Full Text] [Related]

  • 26. The ENDOTRIAL study: a spontaneous, open-label, randomized, multicenter, crossover study on the efficacy of sildenafil, tadalafil, and vardenafil in the treatment of erectile dysfunction.
    Jannini EA, Isidori AM, Gravina GL, Aversa A, Balercia G, Bocchio M, Boscaro M, Carani C, Corona G, Fabbri A, Foresta C, Forti G, Francavilla S, Granata AR, Maggi M, Mansani R, Palego P, Spera G, Vetri M, Lenzi A, Endotrial Study Group.
    J Sex Med; 2009 Sep; 6(9):2547-60. PubMed ID: 19570039
    [Abstract] [Full Text] [Related]

  • 27. Do vardenafil and tadalafil have advantages over sildenafil in the treatment of erectile dysfunction?
    Doggrell S.
    Int J Impot Res; 2007 Sep; 19(3):281-95. PubMed ID: 17183346
    [Abstract] [Full Text] [Related]

  • 28. Patterns of switching phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction: results from the Erectile Dysfunction Observational Study.
    Hatzichristou D, Haro JM, Martin-Morales A, von Keitz A, Riley A, Bertsch J, Belger M, Wolka AM, Beardsworth A, EDOS Group.
    Int J Clin Pract; 2007 Nov; 61(11):1850-62. PubMed ID: 17850306
    [Abstract] [Full Text] [Related]

  • 29. Digital Real-world Data Suggest Patient Preference for Tadalafil over Sildenafil in Patients with Erectile Dysfunction.
    von Büren M, Rodler S, Wiesenhütter I, Schröder F, Buchner A, Stief C, Gratzke C, Wülfing C, von Büren J.
    Eur Urol Focus; 2022 May; 8(3):794-802. PubMed ID: 34006491
    [Abstract] [Full Text] [Related]

  • 30. Sildenafil or vardenafil nonresponders' erectile response to tadalafil.
    Ozgur BC, Gonenc F, Yazicioglu AH.
    Urol J; 2009 May; 6(4):267-71. PubMed ID: 20027555
    [Abstract] [Full Text] [Related]

  • 31. Erectile response to vardenafil in men with a history of nonresponse to sildenafil: a time-from-dosing descriptive analysis.
    Hatzichristou DG, Aliotta P, Auerbach S, Barkin J, Lording D, Murdock M, Wilkins HJ, McBride TA, Colopy MW, Carson CC, Patient Response with Vardenafil in Sildenafil Non-Responders (PROVEN) Study Group.
    Clin Ther; 2005 Sep; 27(9):1452-61. PubMed ID: 16291418
    [Abstract] [Full Text] [Related]

  • 32. [Oral tadalafil on alternate days for erectile dysfunction that fails to respond to on-demand sildenafil: a report of 15 cases].
    Du Q, Gu LX, Miao Y, Xing X, Pan BC, Song YS, Wu B.
    Zhonghua Nan Ke Xue; 2013 Apr; 19(4):337-9. PubMed ID: 23678714
    [Abstract] [Full Text] [Related]

  • 33. Quality of erections in men treated with flexible-dose sildenafil for erectile dysfunction: multicenter trial with a double-blind, randomized, placebo-controlled phase and an open-label phase.
    Kadioglu A, Grohmann W, Depko A, Levinson IP, Sun F, Collins S.
    J Sex Med; 2008 Mar; 5(3):726-34. PubMed ID: 18086165
    [Abstract] [Full Text] [Related]

  • 34. Efficacy of sildenafil in an open-label study as a continuation of a double-blind study in the treatment of erectile dysfunction after radiotherapy for prostate cancer.
    Incrocci L, Hop WC, Slob AK.
    Urology; 2003 Jul; 62(1):116-20. PubMed ID: 12837434
    [Abstract] [Full Text] [Related]

  • 35. How new drugs help treat erectile dysfunction.
    Weeks B, Ficorelli CT.
    Nursing; 2006 Jan; 36(1):18-9. PubMed ID: 16394991
    [No Abstract] [Full Text] [Related]

  • 36. Therapy of ED: PDE-5 Inhibitors.
    Shabsigh R.
    Endocrine; 2004 Jan; 23(2-3):135-41. PubMed ID: 15146092
    [Abstract] [Full Text] [Related]

  • 37. Comparing vardenafil and sildenafil in the treatment of men with erectile dysfunction and risk factors for cardiovascular disease: a randomized, double-blind, pooled crossover study.
    Rubio-Aurioles E, Porst H, Eardley I, Goldstein I.
    J Sex Med; 2006 Nov; 3(6):1037-1049. PubMed ID: 17100937
    [Abstract] [Full Text] [Related]

  • 38. An open-label, multicenter, randomized, crossover study comparing sildenafil citrate and tadalafil for treating erectile dysfunction in Chinese men naïve to phosphodiesterase 5 inhibitor therapy.
    Bai WJ, Li HJ, Dai YT, He XY, Huang YR, Liu JH, Sorsaburu S, Ji C, Jin JJ, Wang XF.
    Asian J Androl; 2015 Nov; 17(1):61-7. PubMed ID: 25370206
    [Abstract] [Full Text] [Related]

  • 39. Dapoxetine, a novel treatment for premature ejaculation, does not have pharmacokinetic interactions with phosphodiesterase-5 inhibitors.
    Dresser MJ, Desai D, Gidwani S, Seftel AD, Modi NB.
    Int J Impot Res; 2006 Nov; 18(1):104-10. PubMed ID: 16307008
    [Abstract] [Full Text] [Related]

  • 40. Efficacy and treatment satisfaction with on-demand tadalafil (Cialis) in men with erectile dysfunction.
    Skoumal R, Chen J, Kula K, Breza J, Calomfirescu N, Basson BR, Kopernicky V.
    Eur Urol; 2004 Sep; 46(3):362-9; discussion 369. PubMed ID: 15306109
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.